Skip to main content
. 2022 Nov 16;141(11):1308–1315. doi: 10.1182/blood.2022017863

Figure 2.

Figure 2.

Kaplan-Meier survival of patients with NDMM according to del(1p32) status. The blue curve corresponds to patients without del(1p32), the yellow curve to patients with a monoallelic del(1p32), and the red curve to patients with a biallelic del(1p32). P values are determined by the log-rank test comparison. (A) Overall survival. (B) Progression-free survival.